September 21, 2022 Meet the Expert

Meet the Expert: Sharon Charles

Read Blog Post
September 20, 2022 Regulatory Sciences

Challenges, Lessons Learned, and Guidance for the Clinical Development of...

It comes as no surprise to any pharmaceutical or biotech company that…

Read Blog Post
September 14, 2022 Regulatory Sciences

How to Comply with the Nitrosamine Regulations for Your New...

Introduction: Are you in the development phase for your medicinal product? Have…

Read Blog Post
September 13, 2022 Press Releases

ProPharma Group announces the appointment of Bryan Katz as new...

ProPharma Group (PPG), a portfolio company of Odyssey Investment Partners, announces the…

Read Blog Post
September 7, 2022 Meet the Expert

Meet the Expert: Anders Nyholm

Our “Meet the Expert” series introduces you to our team of experts…

Read Blog Post
September 1, 2022 Press Releases

ProPharma Group Announces Acquisition of Kateric, An Industry-Leading Medical Writing...

Chicago, IL, September 1, 2022 — ProPharma Group (PPG), the leading global…

Read Blog Post
August 30, 2022 Life Science Consulting

USP and FDA Propose Updates to Good Storage and Distribution...

Updates have been announced by FDA and for USP <1079>. In this…

Read Blog Post
August 29, 2022 Meet the Expert

Meet the Expert: Lucy Radley

Our “Meet the Expert” series introduces you to our team of experts…

Read Blog Post
August 26, 2022 Agency Alerts

FDA Announces Availability of Multiple Draft Guidances – Drug Information...

Today, FDA announced the availability of the following draft guidances for industry,…

Read Agency Alert

Your Business has Complex Challenges. ProPharma Group has Exceptional Solutions.

We partner with pharmaceutical, biotechnology, and medical device clients to tackle complex challenges. Contact us to learn how our experienced team can help ensure regulatory and development success throughout the product lifecycle.

Interested in gaining an industry edge? Let us help you stay up to date.


All fields are required.
There was a problem with your submission. Errors have been highlighted below.